CN1060079C - Chinese herbal medicine composition for curing leukemia - Google Patents
Chinese herbal medicine composition for curing leukemia Download PDFInfo
- Publication number
- CN1060079C CN1060079C CN97108407A CN97108407A CN1060079C CN 1060079 C CN1060079 C CN 1060079C CN 97108407 A CN97108407 A CN 97108407A CN 97108407 A CN97108407 A CN 97108407A CN 1060079 C CN1060079 C CN 1060079C
- Authority
- CN
- China
- Prior art keywords
- herbal medicine
- chinese herbal
- rhizome
- medicine composition
- leukemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention belongs to a Chinese herbal medicine composition for curing leukemia. The Chinese herbal medicine composition with the functions of strengthening the spleen, tonifying the kidney and clearing heat is adopted according to different symptoms of leukemia patients in different pathogenic periods, and the medication is flexibly regulated for matched application. Four groups of recipes are composed of more than 30 kinds of Chinese herbal medicine such as pilose asiabell root, astragalus root, white atractylodes rhizome, tuckahoe, dried tangerine peel, nutgrass galingale rhizome, bupleurum root, lalang grass rhizome, atractylodes rhizome, monkshood, dried ginger, cassia twig, prepared rhizome of rehmannia, cornaceae, etc. Clinical application proves that the curative ratio of the present invention reaches 94%.
Description
The present invention relates to treat leukemic herbal composite, belong to the Chinese medicine technical field.
Leukemia is one of more refractory disease of blood system.Doctor trained in Western medicine generally adopts chemotherapy at present, and the toxic and side effects that chemotherapy produced to the human body infringement greatly, and the patient often can not get satisfied effect, but causes adverse consequencess such as health immunologic hypofunction on the contrary.For avoiding the western medical treatment defective, in China medical circles once the someone release with the leukemic scheme of controlling of executing of herbal composite treatment, but the problem one that exists in compatibility of drugs is the organic connections of having ignored the human five internal organs, compatibility of drugs is unreasonable, so that pharmacology is obstructed; The 2nd, stick to a side one disease, be confined to the symptom performance in a certain stage of patient disease and only play single heat clearing away, yin nourishing, invigorate blood circulation, benefiting action, therefore can not reach the leukemic purpose of effective treatment.
Goal of the invention of the present invention is to avoid and overcomes above-mentioned the deficiencies in the prior art and release a kind of with the effective leukemic herbal composite of treatment of strengthening spleen, tonifying kidney clearing away heat method.In treatment, be not limited to a side one disease, adopt spleen invigorating, the kidney invigorating, heat clearing away to use simultaneously; Or based on heat clearing away, or based on the kidney invigorating, or based on spleen invigorating.Be that the kidney invigorating heat clearing away is not forgotten in spleen invigorating, the spleen invigorating heat clearing away is not forgotten in the kidney invigorating, and heat clearing away does not forget to nurse one's health the spleen kidney.Demonstrate fully dialectical with debate disease organic synthesis dialectical opinion together and control thought.
Goal of the invention of the present invention can be achieved by the following technical programs: because leukemia shows anemia, hemorrhage, infection three big symptoms clinically, it is generally acknowledged how this disease is caused by factors such as ionizing radiation, chemical substance and virus, heredity, immunity, body fluid.By clinical observation for many years, according to the pathogen and pathology of tcm theory, think that this disease is by plain body spleen kidney deficiency, lose in the healthy energy, the pathogen invasion, with the passing of time heat-transformation, evil poison is invaded blood, flows into bone marrow, influences function of five internal organs and forms.The kidney governing bones marrow, splenaemia.Leukemia disease feelings complexity, the pathogenesis deficiency syndrome mingling with excess syndrome, in line with starting with from the spleen kidney, the principle of the heat clearing away heresy of holding concurrently can be effective when clinical treatment.So acute and chronic leukemia no matter: if asthenia of both the spleen and kidney appears in the patient, symptomes complices such as pathogenic heat remaining in the interior, the composition of the herbal composite that should adopt and shared weight hundred are than being: who ground 6%, the Radix Rehmanniae 6%, Cortex Phellodendri 6%, the Rhizoma Anemarrhenae 6%, mountain cornel 6%, Cortex Lycii 6%, Radix Codonopsis 6%, Rhizoma Polygonati 6%, the Radix Paeoniae Alba 6%, Rhizoma Dioscoreae 6%, Rhizoma Imperatae 6%, Herba Scutellariae Barbatae 10%, Radix Angelicae Sinensis 6%, the Radix Astragali 11%, Rhizoma Coptidis 3%.
Good effect of the present invention is: first has avoided the infringement of the toxic and side effects of doctor trained in Western medicine chemotherapy to human body; The second spleen kidney deficiency according to the clinical appearance of patient, that accumulates in the pathogenic heat is ripe light ripe heavy, adopts the principle of medication of strengthening spleen, tonifying kidney heat clearing away, organically combines debating disease and debating disease.And be not limited to a side one disease.Having used the present invention since 90 years treats the numerical example patient and obtains beyond thought therapeutic effect.As following table:
Age group | Number | Alleviate fully | Part is alleviated | |||
Under-18s | The man | 6 | 6 | |||
The woman | 3 | 3 | ||||
19-49 year | The man | 6 | 6 | |||
The woman | 2 | 2 | ||||
More than 50 years old | The man | 1 | 1 | |||
The woman | ||||||
Add up to | 18 | 17 | 1 |
Alleviate fully: 17 examples, cure rate accounts for 94%;
Part is alleviated: 1 example accounts for 6%
Embodiment: according to theory of Chinese medical science kidney governing bones marrow, The spleen governs the blood, establishing principle of the present invention is that conditioning spleen kidney is main, the heat clearing away heresy of holding concurrently simultaneously.Adopt spleen invigorating, the kidney invigorating, heat clearing away to use simultaneously, pay attention to spleen kidney and the effect of evil poison in each pathological process of leukemia.The spleen kidney deficiency, in the healthy energy thanks to be this disease this, pathogen invasion, with the passing of time heat-transformation, evil poison is invaded blood system, flows in bone marrow, the infringement function of five internal organs is the target pathology thought of primary disease,
If the patient is asthenia of both the spleen and kidney, pathogenic heat remaining in the interior person, then should select following herbal composite of the present invention for use:
Who ground 10g, Radix Rehmanniae 10g, Cortex Phellodendri 10g, Rhizoma Anemarrhenae 10g, mountain cornel 10g, Cortex Lycii 10g, Radix Codonopsis 10g, Rhizoma Polygonati 10g, Radix Paeoniae Alba 10g, Rhizoma Dioscoreae 10g, Rhizoma Imperatae 10g, Herba Scutellariae Barbatae 15g, Radix Angelicae Sinensis 10g, Radix Astragali 18g, Rhizoma Coptidis 5g.
Instructions of taking of the present invention is to be decocted in water for oral dose, 1 day 1 dose, morning and evening service once, 10 doses was 1 course of treatment.
Medical record is given an example: Zhao * *, woman, 13 years old.The Shunyi County people of Beijing, 1988 is " leukemia " at Beijing hospital diagnosis, successively in Tianjin, ground treatment unsatisfactory curative effects such as Beijing, Xi'an.Going to a doctor in the here of coming March 10 nineteen ninety, examines its pale complexion, spiritlessness and weakness.The lazy speech of breathing hard, cardiopalmus, soreness of the waist and knees, eyelid is pale, the bluish lip purple, bleeding from the gum, the time epistaxis, thirsty, light red tongue, tongue is greasy in vain, thready and rapid pulse.Laboratory examination: WBC107.0 * 10
9/ L, RBC1.4 * 10
12/ L, Hb40g/L, mirror hematochezia sheet is found original and juvenile white cell.The remarkable hypertrophy of bone marrow smear, leukemia germinal cell are up to 67%, and cell peroxidating stone roller karyomere cell series monocytic series is classified the positive as, and lymphocyte is tied to negative, is diagnosed as " chronic leukemia acute attack ".Disease belongs to asthenia of both the spleen and kidney, pathogenic heat remaining in the interior.Use above-mentioned composition of the present invention, adjust to use with disease, use 10 courses of treatment continuously after, patient's spirit is good, appetite increases, and has not felt weak, 10 doses of the band medicines of continuing to consolidate curative effect, are followed up a case by regular visits to not recurrence again in 3 years.
The present invention shows through zoopery, has no side effect and other untoward reaction.
Claims (1)
1, the leukemic herbal composite of a kind of treatment is characterized in that the composition of said composition and shared percentage by weight are:
Who ground 6% Radix Rehmanniae, 6% Cortex Phellodendri, 6% Rhizoma Anemarrhenae 6%
Mountain cornel 6% Cortex Lycii 6% Radix Codonopsis 6% Rhizoma Polygonati 6%
The Radix Paeoniae Alba 6% Rhizoma Dioscoreae 6% Rhizoma Imperatae 6% Herba Scutellariae Barbatae 10%
Radix Angelicae Sinensis 6% Radix Astragali 11% Rhizoma Coptidis 3%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97108407A CN1060079C (en) | 1997-01-17 | 1997-01-17 | Chinese herbal medicine composition for curing leukemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97108407A CN1060079C (en) | 1997-01-17 | 1997-01-17 | Chinese herbal medicine composition for curing leukemia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1188012A CN1188012A (en) | 1998-07-22 |
CN1060079C true CN1060079C (en) | 2001-01-03 |
Family
ID=5170397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97108407A Expired - Fee Related CN1060079C (en) | 1997-01-17 | 1997-01-17 | Chinese herbal medicine composition for curing leukemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1060079C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1098698C (en) * | 1998-07-31 | 2003-01-15 | 张发誉 | Medicinal pill for treating leukemia |
CN1094058C (en) * | 1999-06-02 | 2002-11-13 | 湖南医科大学附属湘雅医院 | Tolerant Chinese medicine preparation for treating leukemia |
-
1997
- 1997-01-17 CN CN97108407A patent/CN1060079C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
中医杂志1987,28(10) 1987.1.1 吴正翔等,靛玉红与中药联用治疗慢性粒细胞白血病40例对比 * |
中西医结合杂志1984(4) 1984.1.1 张亭栋等,癌灵1号治疗急性粒细胞白血病临床分析及实验研究 * |
中西医结合杂志1984(4) 1984.1.1 张亭栋等,癌灵1号治疗急性粒细胞白血病临床分析及实验研究;中医杂志1987,28(10) 1987.1.1 吴正翔等,靛玉红与中药联用治疗慢性粒细胞白血病40例对比 * |
Also Published As
Publication number | Publication date |
---|---|
CN1188012A (en) | 1998-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine | |
CN101284121B (en) | Combination medicine for curing the hoary hair | |
CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
CN100434107C (en) | Acne clearing decoction | |
CN101195001A (en) | Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia | |
CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
CN1131053C (en) | Chinese medicine for treating diabetes | |
CN101347601A (en) | Chinese medicine for treating gynecology disease and preparation method thereof | |
CN101164593A (en) | Oral liquid for treating kidney disease | |
CN102614442A (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN101670089A (en) | Traditional Chinese medicine for treating acute gastroenteritis | |
CN101675967A (en) | Lupus I traditional Chinese medicine composition | |
CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
CN1060079C (en) | Chinese herbal medicine composition for curing leukemia | |
CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
CN103656595A (en) | Traditional Chinese medicine composition for treating metrorrhagia | |
CN1686227A (en) | Menstruation regulating powder | |
CN102397438A (en) | Medicine for treating low renal function | |
CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
CN1260209A (en) | Medicine for nephritis | |
CN101062245A (en) | Chinese traditional medicine agent for treating children nephropathy syndrome | |
CN1583073A (en) | Chinese patent medicinal prescription for catch-cold | |
CN102614420A (en) | Chinese medicine preparation for curing atrophic glossitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |